semaglutide day 1 Zydus plans to launch innovative Injection in India on of patent expiry, expanding patient access to GLP-1 therapy. #Zydus #ZydusGroup #SemaglutideInjection #GLP1Therapy Semaglutide Injections Kirkland & Bellevue
Description
The Most Undertreated Chronic Disease: Addressing Obesity in Primary Care Settings
Good news: there are other GLP-1 alternatives besides Ozempic that give you more options than you realize
In October 2017, following a unanimous FDA Advisory Committee approval, the injectable version (Ozempic) was approved for diabetes treatment in the US and later in other countries, including: Canada European Union Japan Australia The oral version (Rybelsus) received US approval in September 2019, with EU approval in April 2020
Until then, the efficacy claims rest on ingredient-level research and preclinical data rather than product-specific human trial outcomes
